DPM ASX Week ended 07 Aug 2026

Weekly Investor Report

DPMMETALS CDI 1:1 [DPM] · Basic Materials · Gold

Open interactive chart View report data
Latest close 58.77 AUD
10.9% latest week
Weekly setup

Mixed setup

The weekly trend is not active. Price is 16.4% above the Trend Line and sits at 90.4% of its 52-week range. The latest completed week returned 10.9%, after a 15.7% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks strongly; valuation is expensive relative to peers. The latest news-sentiment score is 61/100. Near-term considerations: price is close to its 52-week high.

Setup score 58 out of 100
Latest Close 58.77 AUD 7 Aug 2026
1W Return 10.9% latest completed week
4W Return 15.7% short-term follow-through
12W Return 27.0% quarterly tape
Trend Breadth 12.8% 6 of 47 weeks active
Volume Ratio 1.8x vs 13-week average
What is working
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Volume is elevated versus the 13-week average, confirming attention.
  • Next-week expectancy is positive at 61.81% based on similar historical setup states.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Activity pressure is negative, which weakens the current setup.
  • Activity pressure is weak, so confirmation is not yet broad enough.
  • 1 reversal markers appear in the recent smart-money tape.
What to watch next
  • Price is close to its 52-week high; watch for continuation or exhaustion.
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 10.9% Latest completed week; four-week move 15.7%. Indicator stack 7/51 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Positive 61.81% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 61/100 3 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is 16.4% above the Trend Line and sits at 90.4% of its 52-week range. The latest completed week returned 10.9%, after a 15.7% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.8x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.4112-week average 0.38

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.41Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers11 reversal markers

No recent accumulation markers. 1 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 15.7% over four weeks, 27.0% over 12 weeks, and - over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W10.9%
4W15.7%
12W27.0%
26W20.5%
52W-
Active trend streak0 weeks
Active weeks in one year6
Trend breadth12.8%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-0.24Latest activity-pressure read.
Pressure change69.3%Four-week change in activity pressure.
Leadership-Latest relative-leadership reading.
RS change-Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks strongly; valuation is expensive relative to peers.

Open full factor analysis
Factor week 09 Aug 2026 Financial statements through 31 Mar 2026 Field coverage 85% Model confidence 79%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength26/100Blend of value, momentum, and quality. Underlying universe rank 75; rank 1 is best.
Value6/100Relative valuation strength. Underlying universe rank 95; rank 1 is best.
Quality98/100Profitability and accounting quality. Underlying universe rank 3; rank 1 is best.
Momentum18/100Medium-term price momentum. Underlying universe rank 83; rank 1 is best.
Growth97/100Revenue and earnings growth. Underlying universe rank 4; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework45/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
25.7x
Price divided by trailing earnings.
Price / sales
11.5x
Market value relative to trailing revenue.
EV / EBITDA
17.9x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
4.5%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
66.7%
Gross profit retained from each unit of revenue.
Operating margin
52.3%
Operating profit retained from revenue.
Free-cash-flow margin
50.0%
Free cash flow generated from revenue.
Return on invested capital
20.4%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
56.6%
Latest one-year revenue growth.
EPS growth
24.6%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
445.7%
Latest one-year free-cash-flow growth.
Piotroski F-score
5/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
0.4%
Cash dividends relative to market value.
Buyback yield
0.4%
Net share repurchases relative to market value.
Shareholder yield
0.8%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-0.8x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment61/100

Weighted news tone is neutral across 3 relevant articles.

2 positive · 0 neutral · 1 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-4.9%Distance below the 52-week high.
13-week volatility6.5%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher14 of 2612 weeks finished lower.
Best week+12.5%Week of 27 Feb.
Worst week-14.4%Week of 20 Mar.
Latest week+10.9%Week of 7 Aug.

Shape of recent returns

Strong gains10
Modest gains4
Flat weeks0
Modest losses4
Sharp losses8
Recent vol6.5%13-week weekly-return volatility.
Base vol6.5%52-week weekly-return volatility.
Up/down split28/18Count of positive and negative weeks in the 52-week window.
Average skew5.9% / -5.2%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape49/100

Trend, activity pressure, participation, and risk combine to a 49/100 tape read.

 Indicator analysis14/100

Latest 12-week confirmation: trend 0/12, activity pressure 0/12, relative leadership 0/12.

Activity pressure 0.41; 1 reversal markers Next-Week ExpectancyPositive 61.81%

Next-week expectancy is positive with a 61.81% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors37/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 7 SVQF45/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 142.0 of 257 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment61/100

Weighted news tone is neutral across 3 relevant articles.

ASX Preview: Australian Shares to Rise on Gold Gains; Capstone Copper Q2 Adjusted Earnings, Revenue Up Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
7 Aug 202658.77 AUD10.9%50.50 AUD46.17 AUD-0.24-218.1KOff
31 Jul 202652.99 AUD4.1%50.12 AUD45.90 AUD-0.40-42.3KOff
24 Jul 202650.91 AUD8.2%49.91 AUD45.74 AUD-0.53-68.5KOff
17 Jul 202647.06 AUD-7.4%49.78 AUD45.63 AUD-0.71-125.9KOff
10 Jul 202650.81 AUD1.6%49.72 AUD45.59 AUD-0.79-93.0KOff
3 Jul 202650.00 AUD10.4%49.51 AUD45.47 AUD-0.96-12.2KOff
26 Jun 202645.28 AUD2.5%49.25 AUD45.36 AUD-1.10-6.3KOff
19 Jun 202644.16 AUD-1.5%49.09 AUD45.36 AUD-1.15-145.5KOff
12 Jun 202644.83 AUD-9.4%48.81 AUD45.39 AUD-1.13-268.8KOff
5 Jun 202649.49 AUD10.1%48.47 AUD45.41 AUD-1.10-99.5KOff
29 May 202644.96 AUD-2.0%47.90 AUD45.30 AUD-1.10-265.0KOff
22 May 202645.87 AUD-0.9%47.51 AUD45.30 AUD-1.03-75.7KOff
15 May 202646.28 AUD-4.3%47.12 AUD45.29 AUD-0.89-128.9KOn
8 May 202648.35 AUD0.9%46.84 AUD45.26 AUD-0.71-148.1KOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context